DOI QR코드

DOI QR Code

Novel 99mTc(CO)3 Complexes with WAY-100635 Moiety for the Development of 5-HT1A Receptor lmaging Agent

  • Choi, Kang-Hyuk (Radioisotope Research Division, Basic Science & Technology Department,Korea Atomic Energy Research Institute) ;
  • Pyun, Mi-Sun (Radioisotope Research Division, Basic Science & Technology Department,Korea Atomic Energy Research Institute) ;
  • Hong, Young-Don (Radioisotope Research Division, Basic Science & Technology Department,Korea Atomic Energy Research Institute) ;
  • Choi, Sun-ju (Radioisotope Research Division, Basic Science & Technology Department,Korea Atomic Energy Research Institute)
  • Published : 2009.05.20

Abstract

The aim of this study is to develop and synthesize $5-HT_{1A}$ receptor imaging agents with WAY-100635 moiety and $^{99m}Tc(CO)_3$ core. WAY-100635 is commonly known as $5-HT_{1A}$ antagonist and its labeled compound ([$^{11}C$] WAY-100635) has been used as effective radioligand for imaging brain $5-HT_{1A}$ receptors with PET(Positron Emission Tomography). However, there are several restrictions in using a radioisotope of C-11 and requires for more effective radioisotopes and ligands. In order to produce a structure most similar to WAY-100635, WAY-100635 derivatives containing a cysteine chelator were designed and confirmed by using in silico (Hyperchem). The novel compounds (7a, 7b, 7c) were prepared in five or 7 steps with yields of 16%, 36% and 42%, respectively and radiolabeled with $[^{99m}Tc(CO)_3(H_2O)_3]^{+}$. The labeling yield was 99% for all the newly synthesized compounds. [$^{99m}Tc(CO)_3$]- WAY-100635 derivatives show a neutral charge which were confirmed by paper electrophoresis.

Keywords

References

  1. Ballinger, J. L.; Reid, R. H.; Gulenchyn, K. Y. J. Nucl. Med. 1988, 29, 1998
  2. Kung, H. F. Sem. Nucl. Med. 1990, 2, 150
  3. Tsoukalas, C.; Papadopoulos, M. S.; Maina, T.; Pirmettis, I. C.; Nock, B. A.; Raptopoulou, C.; Terzis, A.; Chiotellis, E. Nucl. Med. Biol. 1999, 26, 297 https://doi.org/10.1016/S0969-8051(98)00093-6
  4. Xin-hong, D.; Gong-xu, L.; Xue-bin, W. Appl. Radiat. Isot. 2003, 59, 119 https://doi.org/10.1016/S0969-8043(03)00160-X
  5. Drews, A.; Pietzsch, H. J.; Syhre, R.; Seifert, S.; Varnӓs, K.; Hall, H.; Halldin, C.; Kraus, W.; Karlsson, P.; Johnsson, C.; Spies, H.; Johannsen, B. Nucl. Med. Biol. 2002, 29, 389 https://doi.org/10.1016/S0969-8051(02)00296-2
  6. Tsoukalas, C.; Pirmettis, I.; Patsis, G.; Pelecanou, M.; Bodo, K.; Raptopoulou, C. P.; Terzis, A.; Papadopoulos, M.; Chiotellis, E. J. Inorg. Chem. 2003, 93, 213
  7. Leon, A.; Rey, A.; Mallo, L.; Pirmettis, I.; Papadopoulos, M.; Leon, E.; Pagano, M.; Manta, E.; Incerti, M.; Raptopoulou, C.; Terzis, A.; Chiotellis, E. Nucl. Med. Biol. 2002, 29, 217 https://doi.org/10.1016/S0969-8051(01)00295-5
  8. Heimbold, I.; Drews, A.; Kretzschmar, M.; Varnӓs, K.; Hall, H.; Halldin, C.; Syhre, R.; Kraus, W.; Pietzsch, H.-J.; Seifert, S.; Brust, P.; Johannsen, B. Nucl. Med. Biol. 2002, 29, 375 https://doi.org/10.1016/S0969-8051(01)00313-4
  9. Heimbold, I.; Drews, A.; Syhre, R.; Kretzschmar M.; Pietzsch, H. J.; Johannsen B. Euro. J. Nucl. Med. 2002, 29, 82 https://doi.org/10.1007/s00259-001-0660-x
  10. Satpati, D.; Bapat, K.; Mukherjee, A.; Banerjee, S.; Kothari, K.; Venkatesh, M. Appl. Radiat. Isot. 2006, 64, 888 https://doi.org/10.1016/j.apradiso.2006.03.003
  11. Kieffer, D. M.; Cleynhens, B. J.; Vanbilloen, H. P.; Rattat, D.; Terwinghe, C. Y.; Mortelmans, L.; Bormans, G. M.; Verbruggen, A. M. Bioorg. Medi. Chem. Lett. 2006, 16, 382 https://doi.org/10.1016/j.bmcl.2005.09.071
  12. Maiti, D. K.; Chakraborty, P. K.; Chugani, D. C.; Muzik, O.; Mangner, T. J.; Chugani, H. T. Appl. Radiat. Isotop. 2005, 62, 721 https://doi.org/10.1016/j.apradiso.2004.10.005
  13. Pike, V. W.; Halldin, C.; McCarron, J. A.; Lundkvist, C.; Hirani, E.; Olsson, H.; Hume, S. P.; Karlsson, P.; Osman, S.; Swahn, C. G.; Hall, H.; Wikström, H.; Mensonidas, M.; Poole, K. G.; Farde L. Euro. J. Nucl. Med. 1998, 25, 338 https://doi.org/10.1007/s002590050230
  14. McCarron, J. A.; Marchais-Oberwinkler, S.; Pike, V. W.; Tarkiainen, J.; Halldin, C.; Sóvagó, J.; Gulyas, B.; Wikström, H. V.; Farde, L. Mol. Imaging. Biol. 2005, 7, 209 https://doi.org/10.1007/s11307-005-4127-5
  15. Andree, B.; Halldin, C.; Pike, V. W.; Gunn, R. N.; Olsson, H.; Farde, L. J. Nucl. Med. 2002, 43, 292
  16. Dileep Kumar, J. S.; John Mann, J. Drug discovery today 2007, 12, 748 https://doi.org/10.1016/j.drudis.2007.07.008
  17. Karramkam, M.; Hinnen, F.; Berrehouma, M.; Hlavacek, C.; Vaufrey, F.; Halldin, C.; Mccarron, J. A.; Pike, V. W.; Dolle, F. Bioorg. Med. Chem. 2003, 11, 2769 https://doi.org/10.1016/S0968-0896(03)00225-6
  18. Lang, L.; Jagoda, E.; Ma, Y.; Sassaman, M. B.; Eckelan, W. C. Bioorg. Med. Chem. 2006, 14, 3737 https://doi.org/10.1016/j.bmc.2006.01.064
  19. Vandecapelle, M.; Dumont, F.; Vos, F. D.; Strijckmans, K.; Leysen, D.; Audenarert, K.; Dierckx, R. A.; Slegers, G. J. Label Compd. Radiopharm. 2004, 47, 531 https://doi.org/10.1002/jlcr.837
  20. Alberto, R.; Schibli, R.; Abram, U.; Egli, A.; Knapp, F. F.; Schubigger, P. A. Radiochemica Acta 1997, 79, 99
  21. Alberto, R.; Schibli, R.; Egli, A.; Schubiger, P. A. J. Am. Chem. Soc. 1998, 120, 7987 https://doi.org/10.1021/ja980745t
  22. Choi, K. H.; Hong, Y. D.; Choi, O. J.; Choi, S. J. Bull. Korean Chem. Soc. 2006, 27, 1189 https://doi.org/10.5012/bkcs.2006.27.8.1189
  23. Choi, K. H.; Hong, Y. D.; Choi, O. J.; Choi, S. J. Bull. Korean Chem. Soc. 2006, 27, 1689 https://doi.org/10.5012/bkcs.2006.27.10.1689
  24. Young, R. C.; Mitchell, R. C.; Brown, T. H.; Ganellin, C. R.; Griffiths, R.; Jones, M.; Rana, K. K.; Saunders, D.; Smith, I. R.; Sore, N. E. J. med. Chem. 1988, 31, 656 https://doi.org/10.1021/jm00398a028

Cited by

  1. 세로토닌 5-HT1A수용체 방사성 추적자 18F-Mefway의 합성과 소동물 뇌 PET 연구 vol.9, pp.11, 2009, https://doi.org/10.5392/jkca.2009.9.11.262
  2. A Homobivalent SPECT Radioligand ‐ Serinol Appended Methoxyphenyl Piperazine Derivative for Serotonin Receptor Imaging** vol.6, pp.23, 2021, https://doi.org/10.1002/slct.202100549